I emailed Julian about the issue above and below is his response:
"The actual sales for the quarter were $2.5M, with CardioCel sales close to $1M for the quarter so these were much stronger. The sales in the medical distribution were softer, some of this is timing due to January.
The difference between invoicing actual sales and receipts from customers is a timing issue hence we have stated sales were up at $2.5M although from an accounting timing perspective the receipts from customers was $1.941M.
So we did have a stronger month across the group and we are seeing quarter on quarter sales growth for CardioCel."
Quarterly, page-105
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |